Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis

Ixekizumab significantly improves symptoms of psoriatic arthritis in patients naive to prior biologic therapy and in patients who had failed prior to biologic therapy.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news